Cargando...

Combination treatment in the management of type 2 diabetes: focus on vildagliptin and metformin as a single tablet

Vildagliptin is a potent and selective inhibitor of dipeptidyl peptidase-IV (DPP-4), orally active, that improves glycemic control in patients with type 2 diabetes (T2DM) primarily by enhancing pancreatic (α and β) islet function. Thus vildagliptin has been shown both to improve insulin secretion an...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Halimi, Serge, Schweizer, Anja, Minic, Biljana, Foley, James, Dejager, Sylvie
Formato: Artigo
Idioma:Inglês
Publicado: Dove Medical Press 2008
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2515409/
https://ncbi.nlm.nih.gov/pubmed/18827867
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!